Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genotype 1 Hepatitis C Virus”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00230854
What this trial is testing

Study in Non-responder Hepatitis C Genotype 1 Patients With EMZ702, Pegylated Interferon and Ribavirin

Who this might be right for
Chronic Hepatitis CHepatitis, Viral, Human
OPKO Health, Inc. 28
Not applicableStudy completedNCT00854802
What this trial is testing

Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients

Who this might be right for
Chronic Hepatitis C
Debiopharm International SA 290
Large-scale testing (Phase 3)UnknownNCT00485342
What this trial is testing

RIBAJUSTE Clinical Trial Investigating the Efficacy and Safety of Dose Adaptation of Ribavirin

Who this might be right for
Chronic Hepatitis C
Hospices Civils de Lyon 236
Testing effectiveness (Phase 2)WithdrawnNCT02556086
What this trial is testing

A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Hepatitis C
Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT01391117
What this trial is testing

TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin

Who this might be right for
Hepatitis C Virus
Tibotec BVBA 14
Testing effectiveness (Phase 2)Study completedNCT01466790
What this trial is testing

TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

Who this might be right for
Hepatitis C
Janssen R&D Ireland 168
Testing effectiveness (Phase 2)Study completedNCT01458535
What this trial is testing

Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-Naïve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C Virus
AbbVie (prior sponsor, Abbott) 61
Testing effectiveness (Phase 2)Study completedNCT01482390
What this trial is testing

Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Hoffmann-La Roche 80
Not applicableStudy completedNCT01980290
What this trial is testing

Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis, Chronic
Janssen Pharmaceutica N.V., Belgium 50
Large-scale testing (Phase 3)Study completedNCT01290679
What this trial is testing

An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants

Who this might be right for
Hepatitis C
Janssen R&D Ireland 393
Large-scale testing (Phase 3)Ended earlyNCT01467479
What this trial is testing

Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 185
Early research (Phase 1)Study completedNCT01247194
What this trial is testing

A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1

Who this might be right for
Chronic Genotype 1 Hepatitis C Virus Infection
Presidio Pharmaceuticals, Inc. 24
Large-scale testing (Phase 3)Study completedNCT02597166
What this trial is testing

Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, ChronicCirrhosis, Decompensated
University Health Network, Toronto 14
Post-approval studies (Phase 4)Study completedNCT01756079
What this trial is testing

Evaluate the Efficacy and Safety of Boceprevir Added to Standard of Care Therapy in Previously Treated Participants With Chronic Hepatitis C Genotype 1 and Cirrhosis (MK-3034-105)

Who this might be right for
Hepatitis C
Merck Sharp & Dohme LLC 58
Not applicableStudy completedNCT00724373
What this trial is testing

Study of HCV Genotype 1 Patients in the UK Treated With ViraferonPeg and Rebetol (Study P05269)(COMPLETED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 442
Large-scale testing (Phase 3)Ended earlyNCT01500772
What this trial is testing

Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Debiopharm International SA 6
Testing effectiveness (Phase 2)Study completedNCT01055821
What this trial is testing

Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients

Who this might be right for
Chronic Hepatitis C Infection
Transgene 140
Large-scale testing (Phase 3)Study completedNCT01485991
What this trial is testing

TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to Prior PegINFα-2a and Ribavirin Therapy

Who this might be right for
Hepatitis C
Janssen R&D Ireland 771
Large-scale testing (Phase 3)Study completedNCT03020082
What this trial is testing

Efficacy and Safety of Danoprevir/r + PR 12week Triple Therapy in Treatment Naive Non-Cirrhotic G1 CHC China III

Who this might be right for
Chronic Hepatitis C
Ascletis Pharmaceuticals Co., Ltd. 141
Post-approval studies (Phase 4)Study completedNCT02220868
What this trial is testing

Sofosbuvir, Ribavirin, for the Treatment of Chronic Hepatitis C Virus Genotype 1 in HIV-Coinfected Patients Receiving Fixed Dose Co-formulation Emtricitabine/ Tenofovir/Cobicistat/Elvitegravir: A Pilot Study

Who this might be right for
Hepatitis C InfectionHIV Infection
Saint Michael's Medical Center 10
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation